View Alert
Originator: DHSC & NHS England and Improvement: Supply disruption alert

Issue date: 27-Nov-2019 15:39:19

Action by recipients:
  • Care Trusts
  • Mental Health Trusts
  • Specialists Trusts
  • NHS Regional Offices
  • Learning Disabilities Trusts
  • Mental Health & Social Care Trusts
  • Ambulance Trusts
  • Mental Health & Learning Disabilities
  • Acute Trusts
  • Community Trusts

Information to recipients:
  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • Other contacts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • Social Care Providers (registered with CAS)
  • MHRA (Medicines) Drug Alerts - Non-NHS Recipients
  • GP - Locum
  • NHS 111 and Out of hours providers
  • GP Practices
  • DHSC Supply Disruption - Medicines

Action category: Action

Title: Ranitidine: all formulations. Supply disruption - update.

Broadcast content:
This alert provides an update on the supply status of ranitidine products. Tablets, effervescent tablets, oral solutions and ranitidine injection are all expected to shortly be out of stock with no date for resupply until further notice.

This alert contains advice on the management of affected patients.

This is an update to SDA/2019/005. CAS Liaison Officers should close off SDA/2019/005 if it is still open, noting in the comments box that it has been superceded by this alert.


Additional information: NHS England Regional Offices: please cascade this alert to Community Pharmacy.

Alert reference: SDA/2019/005(U)

Action underway deadline: 29-Nov-2019

Action complete deadline: 28-Feb-2020

Attachments:

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency